Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Home
Investire
Azioni
U.S.A.
NASDAQ
Ambrx Biopharma Inc (AMAM)
Ambrx Biopharma Inc (AMAM) Notizie

Ambrx Biopharma Inc (AMAM)

28,00

0,00

(0,00%)

Chiuso 07 Luglio 10:00PM

0,00

0,00

(0,00%)

Dopo le ore di negoziazione: -

Il tuo punto di riferimento per quotazioni in tempo reale, idee e discussioni live.

Premium

Form 15-12G - Securities registration termination [Section 12(g)]

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form POS AM - Post-Effective amendments for registration statement

Form 8-K - Current report

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law Firm

Kuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to Contact Law Firm PR Newswire NEW YORK, Feb. 12...

someguy41

someguy41 7 minuti fa

Its just market makers or some BS. This thing is trash its always been trash and any of us that got suckered into investing deserve this. There's nothing here its a shell game and we're all bag holding idiots.

INEEDMONEY

INEEDMONEY 7 minuti fa

I guess this will never move!! Good job Logan.

JCESOSA

JCESOSA 7 minuti fa

rosemountbomber

rosemountbomber 8 minuti fa

CRNX another good example of a buyout before phase 3 results of their lead candidate.

HyGro

HyGro 11 minuti fa

Sorry, deniers need facts not just their rabid opinions.

stockanalyze

stockanalyze 11 minuti fa

naked short selling must stop. file compliant with sec . i have had no luck with sec filing complaints ever but may be you will. this is real, naked short selling going on and large banks making a ton and manipulating. not uplisting is like promoting such fraud. no reason not to, a low hanging fruit

DrivenByPain

DrivenByPain 12 minuti fa

Executing the Strategy🤑

Execution remained the defining theme throughout the second quarter as Suntex continued strengthening its diversified operating platform across its seven wholly owned subsidiaries serving construction, electrical contracting, infrastructure, land develo

HyGro

HyGro 13 minuti fa

Sorry, deniers need facts not just their rabid opinions.

HyGro

HyGro 14 minuti fa

We're talking about OTC. NASDAQ already pushed NWBO out.

MRJ25

MRJ25 15 minuti fa

One of these days you will be right.

HyGro

HyGro 16 minuti fa

Clearly no "valid clinical design" as FDA wasn't buying it. Just watch, NWBO won't apply for U.S. approval until they do another trial. P3 trial was manipulated.

jcromeenes

jcromeenes 18 minuti fa

I remember about 10 years ago there was a job posting for a job relating to stock market compliance, don't remember the title exactly, and we all got excited. Well, 10 years has passed.

JP313

JP313 22 minuti fa

Get money my g Im pulling for you, I hope this gem of gems come through for you.

US Market News

US Market News 22 minuti fa

Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2026July 6, 2026 9:57 PM
Business WireMitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it

northam43

northam43 27 minuti fa

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -37 (Extreme Bearish). Extreme Overdue: 60 min (60-E-1,60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/6/ipnir1_Status_Report.PNG

northam43

northam43 28 minuti fa

#1.2 SPX Cycles Expanded Report: Current Cycles Between Cycles (CCBC) is -37 (Extreme Bearish). Extreme Overdue: 60 min (60-E-1,60-2), Daily (D-2), Weekly (W-SC-1).

https://investorshub.advfn.com/uimage/uploads/2026/7/6/ipnir1_Status_Report.PNG

Lewrock

Lewrock 31 minuti fa

It is a good position to be in from a cost standpoint. The key to maximizing our gross margin is to articulate our value proposition on a total cost of ownership basis vs our incumbent competition. We don’t need to dramatically undercut the competition. If our power savings saves the customer $10, t

Hey_Its_That_Guy

Hey_Its_That_Guy 32 minuti fa

Lawyers for large companies happen all the time regular sop

jhdf51

jhdf51 32 minuti fa

Meanwhile I really like the future of this company.

JHD

Monroe1

Monroe1 34 minuti fa

Percentage of Shares Shorted
2.73% of the float of CytoDyn has been sold short.
Short Interest Ratio / Days to Cover
CytoDyn has a short interest ratio ("days to cover") of 12.25

Everyone save back a little extra cash and pile on for the moment the news hits that

DrHigh

DrHigh 36 minuti fa

Str8t-talk

Str8t-talk 39 minuti fa

Be sure to mention to Moss if you’re a shareholder.

jammy32

jammy32 45 minuti fa

82 cents to 36 cents.

CrapIsCrap

CrapIsCrap 46 minuti fa

Probably because 95% of all press releases are BS. Fahman has never produced anything other than shares to sell.

Ambrx Biopharma

IsraCann BioSciences (EM)

7.625% Notes 05/29/2032 ...

Epitomee Medical (EM)

RFF3.30%18DEC2042 RFF3.3...

Vanguard Industrials ETF

Truscott Mining

Aptevo Therapeutics

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN

Hai già un account? Accedi

Non hai un account? Registrati

Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.